Company or ticker...

Company or ticker...

Biotech

uniQURE

uniQure is a pioneering gene therapy company dedicated to delivering potentially curative, one-time treatments for rare and severe genetic diseases using its proprietary adeno-associated virus (AAV) technology platform.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

QURE

1.4B

105.1

n/a

27.73%

Key Facts

Ticker

M. Cap

PS

PE

QURE

1.4B

105.1

n/a

YTD

10MA

20MA

50MA

200MA

27.73%

$QURE

Market is closed 💤

01:02 AM

Made with

Copyright 2025 © The Fullstack Investor

The information on this website is for general informational purposes only and does not constitute financial advice. Any investment decisions made based on this content are at your own risk. The Fullstack Investor assumes no liability for the information presented, its accuracy, and completeness. You should conduct your own independent research. The author assumes no liability for any loss or damage arising from reliance on this information.

Market is closed 💤

01:02 AM

Made with

Copyright 2025 © The Fullstack Investor

The information on this website is for general informational purposes only and does not constitute financial advice. Any investment decisions made based on this content are at your own risk. The Fullstack Investor assumes no liability for the information presented, its accuracy, and completeness. You should conduct your own independent research. The author assumes no liability for any loss or damage arising from reliance on this information.

Market is closed 💤

01:02 AM

Made with

Copyright 2025 © The Fullstack Investor

Disclaimer

This content is for informational purposes only and does not constitute financial advice. Please do your own research. No liability is accepted for any loss or damage arising from the use of this content.

Disclaimer

This content is for informational purposes only and does not constitute financial advice. Please do your own research. No liability is accepted for any loss or damage arising from the use of this content.